Xilio Therapeutics, Inc. logo

XLOXilio Therapeutics, Inc.

XLO Stock Price, Valuation & Chart | Xilio Therapeutics, Inc.

Compare

XLO Historical price chart

XLO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization59.44M
PE Ratio-5.58
EPS-1.62
Trading Volume3.91K
Today's High/Low9.14/8.94
Dividend Yield0.00
52 Week High/Low12.74/6.47
Shares Outstanding6.58M
XLO Financial Statement
XLO Analyst ratings
XLO Analysis & performance metrics

XLO Company profile

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program…

XLO Management team

Management
Christopher FrankenfieldCFO
Chief Financial Officer & Chief Operating Officer
Katarina Luptakova M.D.
Chief Medical Officer
Scott Coleman Ph.D.
Chief Development Officer
Kevin M. Brennan
Senior Vice President of Finance & Accounting
Nathan McBrideCTO
Chief Information Officer
Rene Russo BCPS, Pharm.D.CEO
President, Chief Executive Officer & Director
Uli Bialucha Ph.D.
Chief Scientific Officer
Caroline Hensley
Chief Legal Officer
Total 8 executives

XLO Frequently asked questions

What is Xilio Therapeutics, Inc. (XLO) Stock Price?

Current stock price of Xilio Therapeutics, Inc. (XLO) stock is $9.040. The stock price is +1.80% higher in the session. The intraday range can be seen from this page. Volume of Xilio Therapeutics, Inc. (XLO) stock is 3.91K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the Xilio Therapeutics, Inc. (XLO) stock price going up or down today?

The stock price of Xilio Therapeutics, Inc. (XLO) can change with earnings, company news, and overall market sentiment. Xilio Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Xilio Therapeutics, Inc. stock expensive at its current price?

Whether Xilio Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XLO on this page is -5.58. EPS on this page is -1.62. Compare those figures with peers and growth expectations before deciding if the current Xilio Therapeutics, Inc. price is justified.

How has the stock price of Xilio Therapeutics, Inc. (XLO) performed historically?

Historical performance for Xilio Therapeutics, Inc. (XLO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XLO reacted to past earnings and market events.

Should I buy Xilio Therapeutics, Inc. (XLO) stock, at this price?

Buying Xilio Therapeutics, Inc. (XLO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.